
Health care special purpose acquisition companies in 2020-2021 represented a temporary market inefficiency that enabled weaker companies to bypass traditional due diligence and ultimately led to failures.
The American Journal of Managed Care
over 28 years ago
Cost of Migraine Management: A Pharmacoeconomic Overviewover 28 years ago
Alzheimer's Disease: Clinical Features and Pharmacologic Managementover 28 years ago
Medicare HMOs: Who Joins and Who Leaves?



